189 related articles for article (PubMed ID: 34111999)
1. High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids.
Choo N; Ramm S; Luu J; Winter JM; Selth LA; Dwyer AR; Frydenberg M; Grummet J; Sandhu S; Hickey TE; Tilley WD; Taylor RA; Risbridger GP; Lawrence MG; Simpson KJ
SLAS Discov; 2021 Oct; 26(9):1107-1124. PubMed ID: 34111999
[TBL] [Abstract][Full Text] [Related]
2. A PDX/Organoid Biobank of Advanced Prostate Cancers Captures Genomic and Phenotypic Heterogeneity for Disease Modeling and Therapeutic Screening.
Beshiri ML; Tice CM; Tran C; Nguyen HM; Sowalsky AG; Agarwal S; Jansson KH; Yang Q; McGowen KM; Yin J; Alilin AN; Karzai FH; Dahut WL; Corey E; Kelly K
Clin Cancer Res; 2018 Sep; 24(17):4332-4345. PubMed ID: 29748182
[No Abstract] [Full Text] [Related]
3. Advancing preclinical drug evaluation through automated 3D imaging for high-throughput screening with kidney organoids.
Oishi H; Tabibzadeh N; Morizane R
Biofabrication; 2024 Apr; 16(3):. PubMed ID: 38547531
[TBL] [Abstract][Full Text] [Related]
4. OrganoID: A versatile deep learning platform for tracking and analysis of single-organoid dynamics.
Matthews JM; Schuster B; Kashaf SS; Liu P; Ben-Yishay R; Ishay-Ronen D; Izumchenko E; Shen L; Weber CR; Bielski M; Kupfer SS; Bilgic M; Rzhetsky A; Tay S
PLoS Comput Biol; 2022 Nov; 18(11):e1010584. PubMed ID: 36350878
[TBL] [Abstract][Full Text] [Related]
5. Preclinical Models of Prostate Cancer: Patient-Derived Xenografts, Organoids, and Other Explant Models.
Risbridger GP; Toivanen R; Taylor RA
Cold Spring Harb Perspect Med; 2018 Aug; 8(8):. PubMed ID: 29311126
[TBL] [Abstract][Full Text] [Related]
6. The combination of breast cancer PDO and mini-PDX platform for drug screening and individualized treatment.
Cui Y; Ran R; Da Y; Zhang H; Jiang M; Qi X; Zhang W; Niu L; Zhou Y; Zhou C; Tang X; Wang K; Yan Y; Ren Y; Dong D; Zhou Y; Wang H; Gong J; Hu F; Zhao S; Zhang H; Zhang C; Yang J
J Cell Mol Med; 2024 May; 28(9):e18374. PubMed ID: 38722288
[TBL] [Abstract][Full Text] [Related]
7. Protocol for high throughput 3D drug screening of patient derived melanoma and renal cell carcinoma.
Ortiz Jordan LM; Vega VF; Shumate J; Peles A; Zeiger J; Scampavia L; Spicer TP
SLAS Discov; 2024 Apr; 29(3):100141. PubMed ID: 38218316
[TBL] [Abstract][Full Text] [Related]
8. High-throughput formation and image-based analysis of basal-in mammary organoids in 384-well plates.
Lee S; Chang J; Kang SM; Parigoris E; Lee JH; Huh YS; Takayama S
Sci Rep; 2022 Jan; 12(1):317. PubMed ID: 35013350
[TBL] [Abstract][Full Text] [Related]
9. Technologies to Assess Drug Response and Heterogeneity in Patient-Derived Cancer Organoids.
Skala MC; Deming DA; Kratz JD
Annu Rev Biomed Eng; 2022 Jun; 24():157-177. PubMed ID: 35259932
[TBL] [Abstract][Full Text] [Related]
10. Prostate Cancer Organoids for Tumor Modeling and Drug Screening.
Yehya A; Ghamlouche F; Hachem S; Abou-Kheir W
Methods Mol Biol; 2024; 2777():135-144. PubMed ID: 38478341
[TBL] [Abstract][Full Text] [Related]
11. Defining the challenges and opportunities for using patient-derived models in prostate cancer research.
Brennen WN; Le Magnen C; Karkampouna S; Anselmino N; Bock N; Choo N; Clark AK; Coleman IM; Dolgos R; Ferguson AM; Goode DL; Krutihof-de Julio M; Navone NM; Nelson PS; O'Neill E; Porter LH; Ranasinghe W; Sunada T; Williams ED; Butler LM; Corey E; van Weerden WM; Taylor RA; Risbridger GP; Lawrence MG
Prostate; 2024 May; 84(7):623-635. PubMed ID: 38450798
[TBL] [Abstract][Full Text] [Related]
12. Vascularized tissue on mesh-assisted platform (VT-MAP): a novel approach for diverse organoid size culture and tailored cancer drug response analysis.
Lee J; Jung S; Hong HK; Jo H; Rhee S; Jeong YL; Ko J; Cho YB; Jeon NL
Lab Chip; 2024 Apr; 24(8):2208-2223. PubMed ID: 38533822
[TBL] [Abstract][Full Text] [Related]
13. Patient-derived response estimates from zero-passage organoids of luminal breast cancer.
Przanowska RK; Labban N; Przanowski P; Hawes RB; Atkins KA; Showalter SL; Janes KA
bioRxiv; 2024 Mar; ():. PubMed ID: 38585922
[TBL] [Abstract][Full Text] [Related]
14. High-throughput drug screening of fine-needle aspiration-derived cancer organoids.
Bergdorf K; Phifer C; Bharti V; Westover D; Bauer J; Vilgelm A; Lee E; Weiss V
STAR Protoc; 2020 Dec; 1(3):100212. PubMed ID: 33377106
[TBL] [Abstract][Full Text] [Related]
15. Patient-derived organoids for personalized gallbladder cancer modelling and drug screening.
Yuan B; Zhao X; Wang X; Liu E; Liu C; Zong Y; Jiang Y; Hou M; Chen Y; Chen L; Zhang Y; Wang H; Fu J
Clin Transl Med; 2022 Jan; 12(1):e678. PubMed ID: 35075805
[TBL] [Abstract][Full Text] [Related]
16. Development of Arrayed Colonic Organoids for Screening of Secretagogues Associated with Enterotoxins.
Gunasekara DB; DiSalvo M; Wang Y; Nguyen DL; Reed MI; Speer J; Sims CE; Magness ST; Allbritton NL
Anal Chem; 2018 Feb; 90(3):1941-1950. PubMed ID: 29281259
[TBL] [Abstract][Full Text] [Related]
17. Organoid technology for personalized pancreatic cancer therapy.
Bengtsson A; Andersson R; Rahm J; Ganganna K; Andersson B; Ansari D
Cell Oncol (Dordr); 2021 Apr; 44(2):251-260. PubMed ID: 33492660
[TBL] [Abstract][Full Text] [Related]
18. Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series.
Anselmino N; Labanca E; Shepherd PDA; Dong J; Yang J; Song X; Nandakumar S; Kundra R; Lee C; Schultz N; Zhang J; Araujo JC; Aparicio AM; Subudhi SK; Corn PG; Pisters LL; Ward JF; Davis JW; Vazquez ES; Gueron G; Logothetis CJ; Futreal A; Troncoso P; Chen Y; Navone NM
Clin Cancer Res; 2024 May; 30(10):2272-2285. PubMed ID: 38488813
[TBL] [Abstract][Full Text] [Related]
19. Non-Invasive Label-free Analysis Pipeline for In Situ Characterization of Differentiation in 3D Brain Organoid Models.
Filan C; Charles S; Casteleiro Costa P; Niu W; Cheng BF; Wen Z; Lu H; Robles FE
Res Sq; 2024 Apr; ():. PubMed ID: 38645145
[TBL] [Abstract][Full Text] [Related]
20. Mammary Tumor Organoid Culture in Non-Adhesive Alginate for Luminal Mechanics and High-Throughput Drug Screening.
Fang G; Lu H; Rodriguez de la Fuente L; Law AMK; Lin G; Jin D; Gallego-Ortega D
Adv Sci (Weinh); 2021 Nov; 8(21):e2102418. PubMed ID: 34494727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
